Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.40 |
| ▸ | APP | P05067 | 4/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.36 |
| ▸ | FASN | P49327 | 1/20 | 0.36 |
| ▸ | LDHA | P00338 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21014524 | 0.77 | KMT2A (0.51) | KMT2ACYP19A1HPGDSLC2A1APP | |
| SCHEMBL9890912 | 0.77 | KMT2A (0.51) | KMT2ACYP19A1HPGDSLC2A1APP | |
| SCHEMBL11524631 | 0.77 | KMT2A (0.58) | KMT2ACYP19A1HPGDSLC2A1APP | |
| SCHEMBL994958 | 0.76 | ACHE (0.45) | ALDH1A1KDM4ELMNAMAPT | |
| SCHEMBL29662092 | 0.76 | ACHE (0.45) | ALDH1A1KDM4ELMNAMAPT | |
| SCHEMBL13042861 | 0.75 | NPC1 (0.50) | KMT2AHPGDSMN1; SMN2ALDH1A1KDM4E | |
| SCHEMBL3738165 | 0.75 | HDAC1 (0.51) | KMT2AHPGDSMN1; SMN2ALDH1A1KDM4E | |
| SCHEMBL14363735 | 0.74 | PLA2G4A (0.43) | KMT2AHSD11B1LDHA | |
| SCHEMBL15196349 | 0.74 | GPR3 (0.53) | KMT2AHPGDSMN1; SMN2ALDH1A1KDM4E | |
| SCHEMBL15196326 | 0.74 | GPR3 (0.53) | KMT2AHPGDSMN1; SMN2ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11765966-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-09-19 | — | — | US | disclosed |
| US-11765966-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-09-19 | — | — | US | disclosed |
| US-20220359836-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2022-11-10 | — | — | US | disclosed |
| US-20210388013-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2021-12-16 | — | — | US | disclosed |
| US-20210070792-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2021-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210070792-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LOXL1, ILK, SOD1 | KMT2A 2987/4885CYP19A1 2410/4885HPGD 3321/4885 |
| US-20210388013-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | ODC1, OCIAD1, OCIAD2 | KMT2A 2842/4885CYP19A1 229/4885HPGD 653/4885 |
| US-20220359836-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | L1CAM, EPCAM, EPM2A | KMT2A 3949/4885CYP19A1 3374/4885HPGD 3134/4885 |
| US-11765966-B2 | Organic electroluminescent materials and devices | L1CAM, EPCAM, EPM2A | KMT2A 3949/4885CYP19A1 3374/4885HPGD 3134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.